Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas|Biofilm Infection in Cystic Fibrosis

• Unité de recherche: INNOSUISSE
• Numéro de projet: 18366.1 PFLS-LS
• Titre du projet anglais: Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas|Biofilm Infection in Cystic Fibrosis

Description succincte (Allemand)

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Description succincte (Anglais)

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas|Biofilm Infection in Cystic Fibrosis

Résumé des résultats (Abstract) (Allemand)

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.

Résumé des résultats (Abstract) (Anglais)

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.